A diagnostic ceiling for exome sequencing in cerebellar ataxia and related neurological disorders.

ataxia cerebellar ataxia cerebellum diagnostic testing exome gait disorders genetics genomics neurogenetics spastic paraparesis spastic paraplegia spinocerebellar ataxia

Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
02 2020
Historique:
received: 14 05 2019
revised: 25 10 2019
accepted: 01 11 2019
pubmed: 7 11 2019
medline: 23 7 2021
entrez: 7 11 2019
Statut: ppublish

Résumé

Genetic ataxias are associated with mutations in hundreds of genes with high phenotypic overlap complicating the clinical diagnosis. Whole-exome sequencing (WES) has increased the overall diagnostic rate considerably. However, the upper limit of this method remains ill-defined, hindering efforts to address the remaining diagnostic gap. To further assess the role of rare coding variation in ataxic disorders, we reanalyzed our previously published exome cohort of 76 predominantly adult and sporadic-onset patients, expanded the total number of cases to 260, and introduced analyses for copy number variation and repeat expansion in a representative subset. For new cases (n = 184), our resulting clinically relevant detection rate remained stable at 47% with 24% classified as pathogenic. Reanalysis of the previously sequenced 76 patients modestly improved the pathogenic rate by 7%. For the combined cohort (n = 260), the total observed clinical detection rate was 52% with 25% classified as pathogenic. Published studies of similar neurological phenotypes report comparable rates. This consistency across multiple cohorts suggests that, despite continued technical and analytical advancements, an approximately 50% diagnostic rate marks a relative ceiling for current WES-based methods and a more comprehensive genome-wide assessment is needed to identify the missing causative genetic etiologies for cerebellar ataxia and related neurodegenerative diseases.

Identifiants

pubmed: 31692161
doi: 10.1002/humu.23946
pmc: PMC7182470
mid: NIHMS1565462
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

487-501

Subventions

Organisme : NHGRI NIH HHS
ID : U54HG003273
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS082094
Pays : United States
Organisme : NINDS NIH HHS
ID : R25 NS065723
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG006542
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : NHGRI NIH HHS
ID : K08 HG008986
Pays : United States
Organisme : NINDS NIH HHS
ID : R01NS058529
Pays : United States
Organisme : NINDS NIH HHS
ID : K08 NS105916
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG061351
Pays : United States
Organisme : NINDS NIH HHS
ID : R25NS065723
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001881
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States
Organisme : NHGRI NIH HHS
ID : U54 HG003273
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS058529
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Lancet Neurol. 2010 Jan;9(1):94-104
pubmed: 20083040
Neurol Genet. 2018 Apr 05;4(3):e232
pubmed: 29629410
Genet Test Mol Biomarkers. 2013 Aug;17(8):588-94
pubmed: 23725007
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Ann Neurol. 2017 Jan;81(1):68-78
pubmed: 27863452
Genet Med. 2014 Jul;16(7):510-5
pubmed: 24406459
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Bioinformatics. 2016 Feb 15;32(4):596-8
pubmed: 26515822
Am J Hum Genet. 2012 Oct 5;91(4):597-607
pubmed: 23040492
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Nature. 2012 Apr 04;485(7397):246-50
pubmed: 22495309
PLoS Genet. 2007 Jun;3(6):e108
pubmed: 17590087
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Handb Clin Neurol. 2018;147:105-123
pubmed: 29325606
Nat Clin Pract Neurol. 2006 Nov;2(11):629-35; quiz 1 p following 635
pubmed: 17057750
Genet Med. 2015 Jul;17(7):578-86
pubmed: 25356970
Am J Hum Genet. 2019 Jul 3;105(1):151-165
pubmed: 31230722
Nucleic Acids Res. 2017 Feb 28;45(4):1633-1648
pubmed: 27980096
Am J Hum Genet. 2013 Oct 3;93(4):607-19
pubmed: 24094742
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Hum Mutat. 2014 Jan;35(1):45-9
pubmed: 24108619
Lancet Neurol. 2007 Mar;6(3):245-57
pubmed: 17303531
Neurol Sci. 2016 Mar;37(3):423-30
pubmed: 26590992
Genet Med. 2018 Oct;20(10):1216-1223
pubmed: 29323667
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Ann Clin Transl Neurol. 2018 Aug 14;5(9):1128-1133
pubmed: 30250868
Bioinformatics. 2016 Jan 15;32(2):292-4
pubmed: 26428292
Neurol Genet. 2017 Jul 18;3(4):e174
pubmed: 28761930
Am J Hum Genet. 2014 Nov 6;95(5):553-64
pubmed: 25439724
Bioinformatics. 2012 Oct 15;28(20):2678-9
pubmed: 22914218
Handb Clin Neurol. 2018;147:11-22
pubmed: 29325607
JAMA Neurol. 2018 May 1;75(5):591-599
pubmed: 29482223
Genet Med. 2018 Jun;20(6):645-654
pubmed: 29095811
JAMA Neurol. 2018 Oct 1;75(10):1234-1245
pubmed: 29913018
J Pediatr. 2012 Jan;160(1):152-7
pubmed: 21840535
JAMA Neurol. 2014 Oct;71(10):1237-46
pubmed: 25133958
J Neurol. 2015 Aug;262(8):1822-7
pubmed: 25976027
Hum Mutat. 2016 Dec;37(12):1340-1353
pubmed: 27528516
Ann N Y Acad Sci. 2016 Feb;1366(1):49-60
pubmed: 26250888
Genet Med. 2020 Mar;22(3):490-499
pubmed: 31607746
Clin Genet. 2007 Jan;71(1):12-24
pubmed: 17204042
Neurol Clin Pract. 2016 Apr;6(2):164-176
pubmed: 27104068
Curr Protoc Hum Genet. 2014 Apr 24;81:7.23.1-21
pubmed: 24763994
Handb Clin Neurol. 2018;147:173-185
pubmed: 29325610
Brain. 2015 Feb;138(Pt 2):276-83
pubmed: 25497598
Nat Genet. 2011 May;43(5):491-8
pubmed: 21478889
Sci Transl Med. 2017 Apr 19;9(386):
pubmed: 28424332
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Nat Genet. 2019 Apr;51(4):649-658
pubmed: 30926972
Neurogenetics. 2013 Nov;14(3-4):225-32
pubmed: 24091540
Brain. 2017 Nov 1;140(11):2860-2878
pubmed: 29053796
JAMA. 2014 Nov 12;312(18):1880-7
pubmed: 25326637
Nat Genet. 2016 Oct;48(10):1107-11
pubmed: 27533299
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
Neurol Genet. 2019 Sep 23;5(5):e357
pubmed: 31750392
Neurol Clin. 2013 Nov;31(4):987-1007
pubmed: 24176420
Am J Hum Genet. 2016 Jan 7;98(1):58-74
pubmed: 26749308
Brain. 2013 Oct;136(Pt 10):3106-18
pubmed: 24030952
Genome Res. 2012 Jun;22(6):1154-62
pubmed: 22522390
Nat Genet. 2000 May;25(1):12-3
pubmed: 10802644
Genome Res. 2012 Aug;22(8):1525-32
pubmed: 22585873
Neurology. 2011 Nov 15;77(20):1853-5
pubmed: 22049201
Am J Hum Genet. 2011 Jul 15;89(1):121-30
pubmed: 21683323
Genet Med. 2018 Nov;20(11):1328-1333
pubmed: 29565419
Ann Neurol. 2018 Jun;83(6):1072-1074
pubmed: 29908061
Genome Biol. 2018 Aug 21;19(1):121
pubmed: 30129428
Nucleic Acids Res. 2014 Jan;42(Database issue):D986-92
pubmed: 24174537
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Lancet Neurol. 2019 May;18(5):492-503
pubmed: 30981321
Genet Med. 2019 Jan;21(1):195-206
pubmed: 29915382
N Engl J Med. 2012 Feb 16;366(7):636-46
pubmed: 22335741
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
Eur J Hum Genet. 2016 Oct;24(10):1460-6
pubmed: 27165006
Am J Hum Genet. 2017 Jul 6;101(1):87-103
pubmed: 28686858
Nat Genet. 2010 Jul;42(7):565-9
pubmed: 20562875
Curr Opin Neurol. 2009 Aug;22(4):419-29
pubmed: 19421057
Hum Genet. 2014 Jan;133(1):1-9
pubmed: 24077912
Nat Commun. 2017 Jun 12;8:15824
pubmed: 28604674
Genet Med. 2018 Dec;20(12):1564-1574
pubmed: 29595814

Auteurs

Kathie J Ngo (KJ)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Jessica E Rexach (JE)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Hane Lee (H)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Lauren E Petty (LE)

Department of Medical Genetics, Vanderbilt University Medical Center, Nashville, Tennessee.

Susan Perlman (S)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Juliana M Valera (JM)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Joshua L Deignan (JL)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Yuanming Mao (Y)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Mamdouh Aker (M)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Jennifer E Posey (JE)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

Shalini N Jhangiani (SN)

The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.

Zeynep H Coban-Akdemir (ZH)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.

Eric Boerwinkle (E)

The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.
Human Genetics Center, University of Texas Health Science Center, Houston, Texas.

Donna Muzny (D)

The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.

Alexandra B Nelson (AB)

Department of Neurology, UCSF Memory and Aging Center, University of California, San Francisco, California.

Sharon Hassin-Baer (S)

Department of Neurology, Chaim Sheba Medical Center, Movement Disorders Institute, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Gemma Poke (G)

Genetic Health Service NZ, Central Hub, Wellington Hospital, Wellington, New Zealand.

Katherine Neas (K)

Genetic Health Service NZ, Central Hub, Wellington Hospital, Wellington, New Zealand.

Michael D Geschwind (MD)

Department of Neurology, UCSF Memory and Aging Center, University of California, San Francisco, California.

Wayne W Grody (WW)

Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Richard Gibbs (R)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.

Daniel H Geschwind (DH)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

James R Lupski (JR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Baylor College of Medicine, Texas Children's Hospital, Houston, Texas.

Jennifer E Below (JE)

Department of Medical Genetics, Vanderbilt University Medical Center, Nashville, Tennessee.

Stanley F Nelson (SF)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Pediatrics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Brent L Fogel (BL)

Department of Neurology, Program in Neurogenetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
Clinical Neurogenomics Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH